A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors
Clinical trial NCT02025803 · COMPLETED
Trial details
- NCT number
- NCT02025803
- Sponsor
- Taiho Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2017-07-07
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.